Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

News Daily News

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Todd Neale

May 04, 2017

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

L.A. McKeown

April 10, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Caitlin E. Cox

February 06, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation CCVVC 2016

My most difficult femoropopliteal case: 69 yo female

Presenter: Jos C. van den Berg

June 15, 2016

Presentation CCVVC 2016

My Most Difficult Femoropopliteal Case

Presenter: Fabrizio Fanelli

June 15, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

Wingman35 Crossing Catheters Recalled Due to Tip Splitting, Separation

Readmission for Critical Limb Ischemia Common and Largely Unplanned

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not?

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

My most difficult femoropopliteal case: 69 yo female

My Most Difficult Femoropopliteal Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content